MNKD's drug was not one of a kind, or first in class and they didn't have the world wide rights ----In fact
AFREZZA's oral inhaled insulin was the 2nd inhaled insulin drug tried - the first oral inhaled insulin FAILED and was taken off the market. So recall the definition of insanity....trying the same thing and expecting different results. Also they had a partner that gave up and returned full control back to MNKD, they didn't want anything to do with it. Just too much competition. So you can see MNKD has very little in common with ACAD. So...get lost....I mean, just saying.
Will give Davis the benefit of the doubt for now - hoping he has some answers tomorrow and he makes a come back ...
Well its not that Davis is a bad speaker, he just not saying what we want to hear.
if Davis says we launch sales on June 1....then I am happy as a clam. If he says the EU NDA will be submitted on June 30....I am exhilarated. If he says...The price of Nuplazid will be $12,750 per year, ie $1062 per month supply well I get happy.....if he says we are now going to initiate a Partner search for the ROW I will die and go to heaven....But he didn't....He didn't come close on most of those issues. And there is the little factoid of the IBB taking it in the Bung. But lets see how he does tomorrow. He needs to check off at least 2 of the above items tomorrow. My guess is 1) Pricing and either 2) Launch date or EU NDA date.
Come on Davis give us something !
I don't think they have to shop it, ...if you build it they will come...is more my thinking and they built it...so its just a matter of time before MRK, JNJ or PFE come knocking at the door. Biotech will always drive you nuts. Hoping to see a smaller sell (small red candle ) tomorrow then a reversal?
Yes, you can buy or sell at the wrong time. The key is if you understand and believe in the science then you know you will do well in the long term. This is one of those Biotech gopher holes you don't see. We have a Billion dollar drug
APPROVED...this is not the time to sell,
ACADIA's management will host a conference call and webcast on Thursday, May 5, 2016, at 5:00 p.m. Eastern Time to discuss ACADIA’s financial results and operations.
I think everyone who buys under $30 is gonna make a nice pay day, But check out the IBB, like 8-9 days of Red and we are holding hands with it.
Still looks like there is room to drop a more, not much support...but the AROON is still in Green territory, maybe will cross down with more selling today.
Type Value Conf.
resist. 39.25 2
resist. 36.14 6
resist. 34.39 9
resist. 32.06 11
resist. 29.70 2
supp 28.17 3
supp 25.69 2
supp 24.52 2
supp 23.63 2
supp 21.24 5
supp 19.23 2
supp 17.32 4
This is hard to believe....
Recent CandleStick Analysis
May-02-2016 Homing Pigeon
Apr-28-2016 Bearish Harami
Take home message if you are that concerned about your profit, SELL. It will always be higher than setting a Sell Stop. The Market Maker will gladly take your SELL STOP SHARES CHEAP and not even say thank you.
So....1) Withdrawal Study-I imagine this is to evaluate what happens if you stop the drug slowly or all at once-what are the effects? 2) Safety Study (data from AD & ADA can be used, I hope this will lower the burden of cost) 3) Drug Interaction Study & "strong CYP3A4 inducer - how is Nuplazid affected by other drugs and by the Cytochrome P450 3A4 system 4) re-analysis of tissue samples from pre-clinical studies. This last #4- I am not clear why this was recommended and what types of markers they are looking for. I imagine we are talking brain tissue.